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Abstract 
Background: The rising incidence of multidrug resistant (MDR) Gram-negative bacteria including Pseudomonas aer-
uginosa has become a serious issue in prevention of its spread particularly among hospitalized patients. It is, however, 
unclear whether distinct conditions such as acute intestinal inflammation facilitate P. aeruginosa infection of verte-
brate hosts.
Methods and results: To address this, we analysed P. aeruginosa infection in human microbiota-associated (hma) 
mice with acute ileitis induced by peroral Toxoplasma gondii challenge. When perorally infected with P. aeruginosa 
at day 3 post ileitis induction, hma mice displayed higher intestinal P. aeruginosa loads as compared to hma mice 
without ileitis. However, the overall intestinal microbiota composition was not disturbed by P. aeruginosa (except 
for lowered bifidobacterial populations), and the infection did not further enhance ileal immune cell responses. 
Pro-inflammatory cytokines including IFN-γ and IL-12p70 were similarly increased in ileum and mesenteric lymph 
nodes of P. aeruginosa infected and uninfected hma mice with ileitis. The anti-inflammatory cytokine IL-10 increased 
multifold upon ileitis induction, but interestingly more distinctly in P. aeruginosa infected as compared to uninfected 
controls. Immune responses were not restricted to the intestines as indicated by elevated pro-inflammatory cytokine 
levels in liver and kidney upon ileitis induction. However, except for hepatic TNF-α levels, P. aeruginosa infection did 
not result in more distinct pro-inflammatory cytokine secretion in liver and kidney of hma mice with ileitis. Whereas 
viable intestinal bacteria were more frequently detected in systemic compartments such as spleen and cardiac blood 
of P. aeruginosa infected than uninfected mice at day 7 following ileitis induction, P. aeruginosa infection did not exac-
erbate systemic pro-inflammatory sequelae, but resulted in lower IL-10 serum levels.
Conclusion: Acute intestinal inflammation facilitates infection of the vertebrate host with MDR bacteria including P. 
aeruginosa and might also pose particularly hospitalized patients at risk for acquisition. Since acute T. gondii induced 
inflammation might mask immunopathology caused by P. aeruginosa, a subacute or chronic inflammation model 
might be better suited to investigate the potential role of P. aeruginosa infection in the aggravation of intestinal 
disease.
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Background
Pseudomonas aeruginosa, a non-fermenting Gram-
negative rod, is one of the most important bacterial 
pathogens responsible for a multitude of opportunistic 
infections in humans, especially in hospitalized patients 
[1]. The strictly aerobic pathogen is the primary cause 
of ventilator-associated pneumonia or superinfection of 
burn wounds associated with a mortality of more than 
30% [2]. Its worldwide increasing resistance to manifold 
antibiotic classes particularly due to extended-spectrum 
β-lactamases, carbapenemases and 16S rRNA methylases 
makes P. aeruginosa to a continuously growing threat 
for immune-compromised individuals, patients suffer-
ing from cystic fibrosis and other pulmonary diseases or 
patients admitted to intensive care units [2–4]. A single 
flagellum and multiple cell surface pili allow motility and 
adherence of P. aeruginosa with surfaces [5], whereas 
biofilm formation, alginate secretion, quorum-sensing 
and an elaborated secretion system contribute to the 
virulence of P. aeruginosa [1, 5]. Earlier studies revealed 
that ingested P. aeruginosa are detectable in human 
fecal samples of healthy volunteers up to 6 days follow-
ing oral administration without occurrence of clinical 
symptoms. Fecal P. aeruginosa loads were lower than 
those that had been ingested and decreased over time 
post challenge [6]. However, admission to a surgical ward 
may increase the risk of peroral P. aeruginosa acquisi-
tion, since the percentage of patients’ stool samples car-
rying P. aeruginosa increased during hospital stay [7]. In 
addition to objects and materials present on wards, the 
human gastrointestinal tract may be an important source 
of P. aeruginosa infection [7]. Recent clinical surveys 
revealed that P. aeruginosa detection rates were signifi-
cantly higher in fecal and mucosal samples derived from 
patients suffering from irritable bowel syndrome [8] or in 
the colonic mucosa of a pediatric patient with ulcerative 
colitis [9] as compared to a healthy individual. Whereas 
the pathogenic potential of P. aeruginosa is well-known, 
its potential contribution to initiation and perpetuation 
of intestinal immunopathological conditions are not 
yet understood. Hence, there is currently a large gap in 
knowledge regarding the interplay of P. aeruginosa, the 
host microbiota and immune system, particularly under 
conditions of intestinal inflammation.
Within 1  week following peroral high dose infection 
with the intracellular parasite Toxoplasma gondii, sus-
ceptible mice develop acute inflammation of the ter-
minal ileum with massive necrosis (pan-ileitis) as well 
as extra-intestinal and systemic sequelae and succumb 
to infection within 7–10  days [10–12]. This fatal hyper-
inflammatory scenario is due to a typical T helper cell 1 
(Th1)-type immunopathology and characterized by an 
overproduction of pro-inflammatory mediators including 
interferon (IFN)-γ, tumor necrosis factor (TNF)-α, nitric 
oxide, interleukin (IL)-6, IL-12 and monocyte chemoat-
tractant protein (MCP)-1 evolving upon parasitic inter-
acting with antigen presenting cells with subsequent 
activation of CD4+ T cells, whereas the T. gondii induced 
anti-inflammatory measures include IL-10 expression 
(reviewed by [13]). We showed earlier that the gut micro-
biota is essential for the initiation and progression of T. 
gondii induced ileitis and that small intestinal inflam-
mation is accompanied by distinct changes in the com-
mensal microbiota composition with Gram-negative 
species such as enterobacteria and Bacteroides/Prevotella 
spp. overgrowing the inflamed ileal lumen [11]. Toll-like 
receptor (TLR)-4 dependent signaling of lipopolysaccha-
ride derived from Gram-negative intestinal commensals 
further perpetuates the hyper-inflammatory process [14, 
15]. Hence, the Th1-type immunopathology underlying 
T. gondii induced ileitis and associated intestinal micro-
biota shifts resemble key features of acute episodes in 
patients suffering from Crohn’s disease [10, 13]. In the 
present study we investigated whether acute small intes-
tinal inflammation predisposes the vertebrate host with a 
human microbiota to infection with multidrug resistant 
(MDR) P. aeruginosa. To address this, mice harboring a 
complex human microbiota were challenged with high 
dose T. gondii infection for ileitis induction and subse-
quently infected with a MDR P. aeruginosa strain. The 
presented results shed further light onto the interplay 
between MDR P. aeruginosa, the host innate and adaptive 




All animal experiments were conducted according to the 
European Guidelines for animal welfare (2010/63/EU) 
with approval of the commission for animal experiments 
headed by the “Landesamt für Gesundheit und Soziales” 
(LaGeSo, Berlin; registration numbers G0097/12 and 
G0039/15). Animal welfare was monitored twice daily by 
assessment of clinical conditions and weight loss of mice. 
Mice suffering from weight loss >20% were euthanized by 
isoflurane treatment (Abbott, Germany) in accordance 
with the guidelines of the local authorities.
Generation of gnotobiotic (secondary abiotic) mice
Female C57BL/6j mice were bred under specific path-
ogen-free conditions in the Forschungsinstitute für 
Experimentelle Medizin (Charité-University Medicine, 
Berlin, Germany). Gnotobiotic (i.e. secondary abiotic) 
mice with a virtually depleted microbiota were gener-
ated as described previously [11]. In brief, 8  weeks old 
mice were transferred to sterile cages and subjected to 
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a broad-spectrum antibiotic treatment for 8–10  weeks 
by adding ampicillin plus sulbactam (1 g/L; Ratiopharm, 
Germany), vancomycin (500  mg/L; Cell Pharm, Ger-
many), ciprofloxacin (200  mg/L; Bayer Vital, Germany), 
imipenem (250  mg/L; MSD, Germany) and metronida-
zole (1  g/L; Fresenius, Germany) to the drinking water 
(ad libitum).
Generation of human microbiota‑associated mice
Fresh fecal samples free of enteropathogenic bacteria, 
viruses and parasites were collected from five individual 
healthy volunteers, dissolved in sterile phosphate buff-
ered saline (PBS; Gibco, life technologies, UK), aliquoted 
and stored at −80  °C as described earlier [16]. Immedi-
ately before reconstitution experiments, individual fecal 
aliquots were thawed, pooled, and the main bacterial 
communities within the donor suspension quantita-
tively assessed by cultural and molecular methods [16]. 
To generate human intestinal microbiota-associated 
(hma) mice, gnotobiotic animals were subjected to pero-
ral fecal transplantations with 0.3 mL of the donor sus-
pension by gavage on 3 consecutive days. The total load 
of bacterial groups between independent experiments 
counted around 1010 colony forming units (CFU) and 
varied less than 0.5 logarithmic orders of magnitude. To 
assure proper establishment of the human microbiota 
in the murine host, mice were kept for at least 3 weeks 
until ileitis induction. Immediately before peroral T. 
gondii infection individual fecal samples were collected 
for quantitative cultural and molecular analyses of main 
intestinal bacterial communities.
Induction of acute ileitis
In order to induce acute ileitis mice harboring a human 
intestinal microbiota were infected perorally with 50 
cysts of T. gondii (ME49 strain) by gavage as described 
previously [11, 14, 17].
Pseudomonas aeruginosa infection
Three days following ileitis induction mice were perorally 
infected with 109 CFU of a MDR P. aeruginosa strain by 
gavage in a total volume of 0.3  mL PBS. The P. aerugi-
nosa isolate was cultured from respiratory material of a 
patient suffering from nosocomial pneumonia and kindly 
provided by Prof. Dr. Bastian Opitz (Charité-University 
Medicine, Berlin, Germany). Of note, the bacterial strain 
displayed antimicrobial sensitivity to fosfomycin and 
colistin only.
Cultural analysis of the intestinal loads of P. aeruginosa
On days 2, 3 and 4 post P. aeruginosa infection individual 
fecal samples were homogenized in sterile PBS, and serial 
dilutions streaked onto Columbia agar supplemented 
with 5% sheep blood (Oxoid, Germany) and Cetrimid 
agar (Oxoid) and incubated in an aerobic atmosphere at 
37  °C for at least 48  h to assess intestinal P. aeruginosa 
loads.
Clinical conditions
Body weights as well as macroscopic and/or micro-
scopic abundance of fecal blood were assessed in indi-
vidual mice on a daily basis by the Guajac method using 
Haemoccult (Beckman Coulter/PCD, Germany).
Sampling procedures
Mice were sacrificed 7 days after ileitis induction by iso-
flurane treatment (Abbott, Germany). Cardiac blood and 
tissue samples from spleen, liver, lung, kidney, mesenteric 
lymph nodes (MLN), ileum and colon were removed 
under sterile conditions. Ileal and colonic samples from 
each mouse were collected in parallel for microbiologi-
cal, immunological, immunohistochemical and histo-
pathological analyses. Experiments were repeated at least 
twice.
Small intestinal lengths and histopathological scores
Small intestinal lengths were determined by measuring 
the distance from the duodenum leaving the stomach to 
the ileal-caecal transition. Ex vivo biopsies derived from 
the terminal ileum were immediately fixed in 5% formalin 
and embedded in paraffin. Sections (5 µm) were stained 
with hematoxylin and eosin (H&E) and subjected to a 
standardized histopathological scoring system ranging 
from 0 to 6 as described earlier [11, 14].
Immunohistochemistry
5  µm thin paraffin sections of ileal ex  vivo biopsies 
were used for in  situ immunohistochemical analysis as 
described previously [18–20]. Primary antibodies against 
CD3 (Polycl.rabbit anti human, DAKO, Denmark; 1:10), 
FOXP3 (FJK-165, eBioscience, Germany; 1:100), B220 
(eBioscience; 1:200) and F4/80 (biot. Clone BM 8 rat 
anti mouse, Life Technologies, USA; 1:100) were used to 
assess T lymphocytes, regulatory T cells (Treg), B lym-
phocytes and macrophages/monocytes, respectively. 
The average number of positively stained cells within at 
least six high power fields (HPF, 0.287 mm2; 400× mag-
nification) were determined by an independent blinded 
investigator.
Cultural survey of intestinal microbiota and bacterial 
translocation
For comprehensive quantitative survey of intestinal 
microbiota composition and translocation of viable 
bacteria to extra-intestinal compartments, colonic 
and ileal luminal contents as well as ex  vivo biopsies 
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derived from MLN, spleen, liver and lung, respectively, 
were homogenized in sterile PBS and analyzed in serial 
dilutions on different solid culture media as described 
earlier [11, 14, 21]. Cardiac blood was incubated in 
thioglycolate enrichment broths (BD Bioscience, Ger-
many) for 1  week at 37  °C and streaked onto solid 
media thereafter. Bacteria were grown at 37  °C for at 
least 2–3 days under aerobic, microaerobic and anaero-
bic conditions.
Molecular analysis of the ileal microbiota
DNA was extracted from fecal samples as described 
previously [11, 22]. In brief, DNA was quantified by 
using Quant-iT PicoGreen reagent (Invitrogen, UK) and 
adjusted to 1  ng per µL. Then, main bacterial groups 
abundant in the murine and human intestinal microbiota 
were assessed by quantitative real-time polymerase chain 
reaction (qRT-PCR) with species-, genera- or group-
specific 16S rRNA gene primers (Tib MolBiol, Ger-
many) as described previously [16, 18, 23] and numbers 
of 16S rRNA gene copies per ng DNA of each sample 
determined.
Cytokine detection in colon, ileum, mesenteric lymph 
nodes, liver, kidney, spleen and serum
Ex vivo biopsies of approximately 1 cm2 (ileum cut lon-
gitudinally) were washed in PBS and placed in 24-flat-
bottom well culture plates (Falcon, Germany) containing 
500 mL serum-free RPMI 1640 medium (Gibco, life tech-
nologies) supplemented with penicillin (100  U/mL, 
Biochrom, Germany) and streptomycin (100  µg/mL; 
Biochrom). After 18  h at 37  °C, culture supernatants 
and serum samples were tested for IFN-γ, TNF-α, MCP, 
IL-12p10, IL-6 and IL-10 by the Mouse Inflammation 
Cytometric Bead Assay (CBA; BD Bioscience) on a BD 
FACSCanto II flow cytometer (BD Bioscience). Nitric 
oxide was determined by the Griess reaction as described 
previously [11].
Statistical analysis
Mean values, medians, standard deviations (SD) and 
levels of significance were determined using appro-
priate tests as indicated (two-tailed Student’s t test, 
Mann–Whitney U test, ordinary one-way ANOVA and 
Kruskal–Wallis test). Two-sided probability (p) values 
≤0.05 were considered significant.
Results
Acute ileitis induction facilitates multidrug resistant P. 
aeruginosa infection of human microbiota‑associated mice
The primary goal of our present study was to investi-
gate the influence of acute intestinal inflammation on 
intestinal infection with MDR P. aeruginosa and its 
interplay with the intestinal commensal microbiota 
and the immune system in the vertebrate host. We first 
addressed whether acute ileitis impacted the intestinal 
colonization capacity of MDR P. aeruginosa. To accom-
plish this, we generated secondary abiotic mice with a 
virtually depleted microbiota by broad-spectrum anti-
biotic treatment and reconstituted these mice with a 
human intestinal microbiota by peroral transplanta-
tion of mixed fecal samples derived from five healthy 
individuals on 3 consecutive days. A comprehensive 
cultural survey of the main intestinal bacterial groups 
abundant in the human gut performed 3  weeks post 
fecal transplantation (and immediately before acute ile-
itis induction) revealed that the human microbiota had 
stably established within the murine host (Fig. 1). Fur-
thermore, loads of respective bacterial groups did not 
differ between cohorts that were subsequently infected 
with MDR P. aeruginosa or remained uninfected 
(Fig. 1).
In order to induce acute ileitis, hma mice were pero-
rally infected with 50 cysts of T. gondii ME 49 strain by 
Fig. 1 Intestinal microbiota composition following human fecal 
transplantations. Gnotobiotic (secondary abiotic) mice were gener-
ated by broad-spectrum antibiotic treatment and subjected to 
peroral transplantations of human feces as described in “Methods” 
section. Three weeks following association with human microbiota 
and immediately before acute ileitis induction, a cultural survey of the 
intestinal microbiota composition was performed on fecal samples 
derived from mice of the P. aeruginosa infection cohort (PA; filled cir-
cles) as compared to the non-infected control group (N; open circles). 
Numbers of viable enterobacteria (EB), enterococci (EC), Gram-pos-
itive rods (GPR), Bacteroides/Prevotella spp. (B/P), Clostridium/Eubac-
terium spp. (C/E) and the total loads (TL) were expressed as colony 
forming units per gram feces (CFU/g). Numbers of animals harboring 
the respective bacterial groups are given in parentheses and medians 
are indicated. Data shown were pooled from three independent 
experiments
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gavage. At day 3 following ileitis induction (a critical time 
point when initial histopathological changes within the 
ileal mucosa can be observed in peroral high dose T. gon-
dii infection [11]), mice were perorally challenged with 
109 CFU P. aeruginosa by gavage. Naive hma mice served 
as uninfected controls. In addition, one separate cohort 
of hma mice without induced ileitis was included into 
the P. aeruginosa infection studies. Interestingly, mice 
with ileitis could be infected by P. aeruginosa and dis-
played median fecal pathogenic loads of approximately 
106 CFU per g that were two to three orders of magni-
tude higher as compared to those determined in hma 
mice without ileitis induction at days 3 and 4 post infec-
tion (p.i.) (p < 0.01 and p < 0.0001, respectively; Fig. 2). 
On day 4 p.i., 73.0% of hma mice without ileitis induction 
were carrying P. aeruginosa, whereas 95.0% of mice with 
an inflamed small intestine harbored the MDR bacteria 
(Fig. 2). Hence, acute small intestinal inflammation ren-
ders hma mice more susceptible to infection with MDR 
P. aeruginosa.
Intestinal microbiota composition in multidrug resistant 
P. aeruginosa infected human microbiota‑associated mice 
suffering from acute ileitis
We next assessed whether MDR P. aeruginosa infection 
of hma mice with induced acute ileitis was accompanied 
by distinct changes in intestinal microbiota composition. 
To address this, mice were sacrificed at day 7 following 
ileitis induction and cultural as well as culture-independ-
ent (i.e. molecular) analyses of intestinal luminal contents 
performed. Cultural analyses revealed total bacterial 
counts of up to 1011 CFU per g feces and increased loads 
of Gram-negative bacterial groups including enterobac-
teria and obligate anaerobic Bacteroides/Prevotella spp. 
(approximately 1010 CFU/g) as well as of enterococci 
(approximately 109–1010 CFU/g) and obligate anaerobic 
Clostridium/Eubacterium spp. (approximately 109–1010 
CFU/g) in ileal and colonic luminal contents of mice suf-
fering from acute ileitis (Fig. 3a). Aerobic Gram-positive 
rods, however, were virtually absent in small and large 
intestines of T. gondii infected mice (Fig.  3a). Notably, 
loads of the main cultivable bacterial groups did not dif-
fer between P. aeruginosa infected and uninfected mice 
with acute ileitis (Fig.  3a). In order to assess fastidious 
and non-cultivable bacteria we additionally performed 
quantitative molecular (i.e. 16S rRNA based) analyses of 
ileal contents. Interestingly, bifidobacterial gene numbers 
were more than two orders of magnitude lower in P. aer-
uginosa infected as compared to uninfected mice with 
acute ileitis (p  <  0.05; Fig.  3b). The remaining bacterial 
groups, however, did not differ between the ilea of both 
cohorts (Fig. 3b), thus confirming results obtained from 
culture.
Clinical, macroscopic and microscopic sequelae 
of multidrug resistant P. aeruginosa infection of human 
microbiota‑associated mice suffering from acute ileitis
We next investigated whether the clinical outcome of 
hma mice with acute ileitis was further deteriorated 
by MDR P. aeruginosa infection. Seven days post ile-
itis induction, blood could be detected microscopically 
or even macroscopically in fecal samples from any of P. 
aeruginosa infected hma mice, but only in 81.9% of hma 
mice without concomitant infection, whereas naive hma 
control animals were unaffected (Fig.  4a). Given that 
acute intestinal inflammation is associated with signifi-
cant shortening of the inflamed gut [11, 16], we meas-
ured the small intestinal lengths of mice at necropsy. 
Both P. aeruginosa infected and uninfected hma mice 
with ileitis displayed comparably shorter small intes-
tines than naive controls (p < 0.001; Fig. 4b). The com-
parable macroscopic sequelae of P. aeruginosa infected 
and uninfected hma mice with acute ileitis were paral-
leled by similar microscopic intestinal inflammatory 
Fig. 2 Kinetic of fecal multidrug resistant P. aeruginosa loads in 
human microbiota-associated mice with and without acute ileitis. 
Human microbiota-associated mice were perorally challenged with T. 
gondii ME49 to induce acute ileitis (ILE; filled circles) and additionally 
infected with MDR P. aeruginosa 3 days following ileitis induction. P. 
aeruginosa infected human microbiota-associated mice without ileitis 
induction (N; open circles) served as controls. Intestinal colonization 
densities were determined in fecal samples at days (d) 2, 3 and 4 
following P. aeruginosa infection by culture and expressed as colony 
forming units per gram feces (CFU/g). Numbers of mice harboring 
P. aeruginosa out of the total number of analyzed mice are given in 
parentheses. Medians (black bars) and significance levels (p values) 
determined by Kruskal–Wallis test are indicated. Data shown were 
pooled from three independent experiments
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changes. At day 7 post ileitis induction hma mice dis-
played destruction of villous architecture, cellular 
shedding into the lumen and massive necrosis of the 
ileal mucosa, irrespective of P. aeruginosa infection, as 
indicated by similarly elevated histopathological scores 
(p < 0.001 vs naive; Fig. 4c). In addition, ileal epithelial 
apoptotic cell numbers were comparably increased in P. 
aeruginosa infected and uninfected mice 7 days follow-
ing ileitis induction (p < 0.001 vs naive; Fig. 4d). Taken 
together, T. gondii induced clinical, macroscopic and 
microscopic small intestinal changes did not further 
worsen upon MDR P. aeruginosa infection.
Fig. 3 Intestinal microbiota analysis in multidrug resistant P. aeruginosa infected human microbiota-associated mice suffering from acute ileitis. 
Human microbiota-associated mice were perorally challenged with T. gondii ME49 to induce acute ileitis as described in "Methods" section. One 
group of mice (PA, filled circles) was additionally infected with MDR P. aeruginosa 3 days following ileitis induction by gavage, whereas non-infected 
mice served as controls with acute ileitis only (N, open circles). Main intestinal bacterial groups were quantified by culture and molecular analysis 
of luminal colon and ileum samples at day 7 post T. gondii infection. a Numbers of viable enterobacteria (EB), enterococci (EC), Gram-positive rods 
(GPR), Bacteroides/Prevotella spp. (B/P), Clostridium/Eubacterium spp. (C/E) and the total bacterial loads (TL) were determined in colonic and ileal 
luminal contents by culture and expressed as colony forming units per gram (CFU/g). b 16SrRNA of the main ileal bacterial groups including entero-
bacteria (EB), enterococci (EC), lactobacilli (LB), bifidobacteria (Bif ), Bacteroides/Prevotella spp. (B/P), Clostridium coccoides group (Clocc), Clostridium 
leptum group (Clept) and total eubacterial loads (TL) are expressed as gene numbers per ng DNA. Numbers of animals harboring the respective 
bacterial group are given in parentheses. Medians and significance levels (p values) determined by Kruskal–Wallis test are indicated. Data shown 
were pooled from three independent experiments
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Fig. 4 Clinical, macroscopic and microscopic sequelae in multidrug resistant P. aeruginosa infected human microbiota-associated mice suffering 
from acute ileitis. Human microbiota-associated mice were perorally challenged with T. gondii ME49 to induce acute ileitis and either additionally 
infected with MDR P. aeruginosa 3 days following ileitis induction (PA; filled bar or circles) or not (N; open bar or circles). Naive mice served as negative 
controls (open diamonds). Clinical, macroscopic and microscopic intestinal changes were assessed at day 7 post ileitis induction: a Abundance of 
bloody diarrhea was determined in fecal samples by the Guajac (Haemoccult) method (in %). Means, standard deviations and numbers of fecal 
blood positive mice out of the total numbers of animals (in parentheses) are indicated. b Absolute small intestinal lengths were measured (in cm) 
and c histopathological changes were determined in H&E stained ileal paraffin sections applying a standardized scoring system. Scores ≥4 (dot-
ted line) indicate severe inflammation (with necrosis). d The average numbers of apoptotic cells (positive for caspase 3; Casp3+) from at least six 
high power fields (HPF, ×400 magnification) per animal were determined microscopically in immunohistochemically stained ileal paraffin sections. 
Numbers of animals (in parentheses), medians and significance levels (p values) determined by Kruskal–Wallis test or ordinary one-way ANOVA are 
indicated. Data shown were pooled from three independent experiments
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Intestinal pro‑inflammatory immune responses 
in multidrug resistant P. aeruginosa infected human 
microbiota‑associated mice with acute ileitis
We next surveyed quantitative small intestinal immune 
cell responses upon MDR P. aeruginosa infection of hma 
mice suffering from acute ileitis applying in  situ immu-
nohistochemistry. At day 7 post ileitis induction, both P. 
aeruginosa infected and uninfected hma mice displayed 
multifold and comparably elevated numbers of T and B 
lymphocytes, Treg as well as of macrophages and mono-
cytes within the ileal mucosa and lamina propria (Fig. 5). 
Hence, T. gondii infection resulted in a profound increase 
of innate and adaptive immune cells in the distal small 
intestines that was, however, not further enhanced by 
MDR P. aeruginosa infection. This was also true for intes-
tinal pro-inflammatory cytokine levels as indicated by 
similarly elevated IFN-γ concentrations in ex vivo biop-
sies derived from ileum and MLN (p < 0.001) and addi-
tionally of IL-12p70 (p < 0.05 and p < 0.01, respectively) 
in the ileum of P. aeruginosa infected and uninfected hma 
mice 7 days following T. gondii infection (Fig. 6a, c). Fur-
thermore, IL-12p70 levels were increased in the MLN of 
uninfected, but not P. aeruginosa infected hma mice with 
ileitis induction (p < 0.05; Fig. 6c). Interestingly, the anti-
inflammatory cytokine IL-10 increased multifold upon 
ileitis induction in either mice (p  <  0.05 and p  <  0.001, 
respectively), but more distinctly in P. aeruginosa infected 
as compared to uninfected hma mice (p < 0.05; Fig. 6c). 
Given that upon peroral T. gondii infection the small, but 
not large intestinal tract has been described as exclusive 
intestinal predilection site of inflammation so far [13], we 
unexpectedly observed elevated IFN-γ secretion even in 
supernatants of colonic ex vivo biopsies at day 7 post ile-
itis induction in either mice (p < 0.001; Fig. 6b).
Extra‑intestinal pro‑inflammatory immune responses 
in multidrug resistant P. aeruginosa infected human 
microbiota‑associated mice with acute ileitis
We next addressed whether MDR P. aeruginosa infec-
tion worsened potential extra-intestinal inflammatory 
responses in hma mice with acute ileitis. Interestingly, 
IFN-γ and nitric oxide secretion increased in ex  vivo 
biopsies taken from liver and kidney until day 7 follow-
ing ileitis induction in both P. aeruginosa infected and 
uninfected hma mice (p < 0.05 to 0.001; Fig. 7), whereas 
nitric oxide levels were slightly lower in the liver of the 
latter as compared to the former (p < 0.05; Fig. 7a). Nota-
bly, hepatic TNF-α concentrations were elevated in P. 
aeruginosa infected hma mice only (p < 0.01; Fig. 7a), but 
renal MCP-1 levels increased exclusively in uninfected 
hma mice with ileitis (p  <  0.01; Fig.  7b). Hence, ileitis 
induction is in fact accompanied by pro-inflammatory 
responses in extra-intestinal compartments. However, 
except for hepatic TNF-α levels MDR P. aeruginosa infec-
tion does not result in more distinct pro-inflammatory 
cytokine responses in liver and kidney of hma mice with 
acute ileitis.
Systemic sequelae of multidrug resistant P. aeruginosa 
infection in human microbiota‑associated mice with acute 
ileitis
We further investigated whether MDR P. aeruginosa 
infection aggravated potential systemic responses upon 
ileitis induction. At day 7 following T. gondii infection, 
pro-inflammatory cytokines including IFN-γ, TNF-α, 
MCP-1, IL-12p70 and IL-6 were elevated in both P. aer-
uginosa infected and uninfected hma mice with ileitis 
as compared to naive controls (p  <  0.05-0.001; Fig.  8a) 
that were accompanied by increased IFN-γ secretion in 
splenic ex  vivo biopsies (p  <  0.001; Fig.  8b). Upon ile-
itis induction, serum IL-10 concentrations increased 
in either hma mice, but less distinctly in P. aerugi-
nosa infected mice as compared to uninfected controls 
(p < 0.001; Fig. 8a). Hence, MDR P. aeruginosa infection 
did not exacerbate systemic pro-inflammatory sequelae 
of acute ileitis, but resulted in lower anti-inflammatory 
responses.
Bacterial translocation following multidrug resistant P. 
aeruginosa infection of human microbiota‑associated mice 
with acute ileitis
We next analyzed whether viable bacteria originating 
from the intestinal microbiota were abundant in extra-
intestinal and systemic compartments of hma mice suf-
fering from acute ileitis, and whether MDR P. aeruginosa 
infection facilitated bacterial translocation. In all MLN 
derived from P. aeruginosa infected and uninfected hma 
mice with ileitis, commensal intestinal bacteria such as 
enterobacteria, enterococci, lactobacilli, Bacteroides/
Prevotella spp. and/or Clostridium/Eubacterium spp. 
could be cultured. In extra-intestinal compartments 
such as liver, however, mean bacterial translocation 
rates were 66.7% ± 9.4 and 85.0% ± 21.2 in P. aeruginosa 
infected and uninfected mice with ileitis, respectively, 
whereas commensal intestinal species could be cultured 
in 63.4% ±  4.8 and 85.0% ±  21.2 of lungs in respective 
cohorts (Fig.  9a). Interestingly, viable intestinal bacte-
ria were more frequently detected in systemic compart-
ments such as spleen and cardiac blood of P. aeruginosa 
infected as compared to uninfected mice at day 7 follow-
ing ileitis induction (mean translocation rates spleen: 
60.0% ± 28.3 vs 36.7% ± 4.7, respectively; cardiac blood: 
40.0% ±  28.3 vs 10.0% ±  14.1, respectively) (Fig.  9a). P. 
aeruginosa could be isolated on average from approxi-
mately 25–40% of respective organ homogenates and 
blood (Fig. 9b; Additional file 1: Figure S1). Notably, no 
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Fig. 5 Small intestinal immune cell responses in multidrug resistant P. aeruginosa infected human microbiota-associated mice suffering from acute 
ileitis. Human microbiota-associated mice were perorally challenged with T. gondii ME49 to induce acute ileitis and either additionally infected with 
MDR P. aeruginosa 3 days following ileitis induction (PA; filled circles) or not (N; open circles). The average number of ileal a T lymphocytes (positive 
for CD3), b regulatory T cells (positive for FOXP3), c B lymphocytes (positive for B220), and d macrophages and monocytes (positive for F4/80) from 
six representative high power fields (HPF, ×400 magnification) per animal was determined microscopically in immunohistochemically stained ileal 
paraffin sections at day 7 post ileitis induction. Naive mice served as negative controls (open diamonds). Numbers of mice (in parentheses), medians 
(black bars) and significance levels (p values) determined by Kruskal–Wallis test or ordinary one-way ANOVA are indicated. Data shown were pooled 
from three independent experiments
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translocating intestinal bacterial species could be cul-
tured from respective extra-intestinal and systemic com-
partments of naive hma mice (not shown).
Discussion
In the present study we were able to show that an acute 
intestinal inflammatory condition facilitates MDR P. 
aeruginosa infection of the vertebrate host. Whereas 
(already fatal) ileal inflammatory changes were similar, 
extra-intestinal sequelae of high dose T. gondii infection 
were further aggravated by subsequent P. aeruginosa 
infection.
Applying a well-known infection model of acute T. 
gondii induced ileitis in (with respect to their microbi-
ota) “humanized” mice, we first verified that prior to ile-
itis induction, human microbiota had stably established 
within the murine host and that microbiota composition 
was comparable in experimental groups that were sub-
sequently infected with MDR P. aeruginosa or remained 
uninfected. These results are in accordance with our 
previous studies, where gnotobiotic (i.e. secondary abi-
otic) mice were replenished with human microbiota 
in order to overcome colonization resistance against 
Campylobacter jejuni. Quantitative molecular analysis 
further revealed that following peroral fecal transplanta-
tion human microbiota could stably establish within the 
intestinal tract for more than 6 weeks [16]. Moreover, we 
showed previously that following peroral infection with 
high doses (i.e. >50 cysts) of T. gondii mice developed a 
distinct Th1-type immunopathology and exhibited an 
overgrowth of the inflamed ileal lumen with commensal 
Gram-negative bacterial species such as Escherichia coli 
Fig. 6 Intestinal cytokine responses in multidrug resistant P. aeruginosa infected human microbiota-associated mice suffering from acute ileitis. 
Human microbiota-associated mice were perorally challenged with T. gondii ME49 to induce acute ileitis and either additionally infected with MDR 
P. aeruginosa 3 days following ileitis induction (PA; filled circles) or not (N; open circles). At day 7 post ileitis induction secretion of distinct pro- and 
anti-inflammatory cytokines were determined in ex vivo biopsies derived from different intestinal compartments including a ileum (IFN-γ and IL-
12p70), b colon (IFN-γ) and c MLN (IFN-γ, IL-12p70, IL-10). Naive mice served as negative controls (open diamonds). Numbers of mice (in parentheses), 
medians (black bars) and significance levels (p values) determined by Kruskal–Wallis test or ordinary one-way ANOVA are indicated. Data shown 
were pooled from three independent experiments
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(E. coli) and Bacteroides/Prevotella spp. [11]. Due to pro-
gressive virulence of the applied T. gondii ME49 strain 
by repeated passages in NMRI “bank” mice for several 
generations, we also subjected hma mice to 50 cysts in 
the present study instead of 100 cysts as in our previous 
reports [10–12, 14, 22, 24–29].
Remarkably, acute ileitis induced by 50 cysts of T. gon-
dii rendered hma mice susceptible to MDR P. aeruginosa 
infection. This is in accordance with our previous studies 
demonstrating that hma mice suffering from small intes-
tinal inflammation could be stably colonized by C. jejuni 
[27]. It is hence tempting to speculate that inflammation 
induced changes of the intraluminal milieu within the 
intestinal tract predisposes the host for infection with 
obligate enteropathogenic species such as C. jejuni, but 
also opportunistic pathogens including P. aeruginosa. 
Our hypothesis is further supported by a study show-
ing that a nonpathogenic intestinal E. coli isolate as well 
as the pathogen Salmonella typhimurium were able to 
outcompete the endogenous microbiota of IL-10−/− 
mice, a murine model of chronic colitis, suggesting that 
growth of Gram-negative enterobacteria is enhanced 
by host mediated intestinal inflammation and follow-
ing modification of the composition of intestinal micro-
biota [30, 31]. Furthermore, in a murine co-infection 
model intestinal colonization capacity of S. typhimurium 
was enhanced by inflammatory changes in the intesti-
nal mucosa and dysbiosis elicited by Plasmodium yoelii 
infection [32].
Given that the intestinal intraluminal milieu is deter-
mined by a plethora of factors including the bacteria 
residing in the intestinal compartments, we performed a 
Fig. 7 Extra-intestinal cytokine responses in multidrug resistant P. aeruginosa infected human microbiota-associated mice suffering from acute 
ileitis. Human microbiota-associated mice were perorally challenged with T. gondii ME49 to induce acute ileitis and either additionally infected 
with MDR P. aeruginosa 3 days following ileitis induction (PA; filled circles) or not (N; open circles). At day 7 post ileitis induction secretion of distinct 
pro-inflammatory cytokines were determined in ex vivo biopsies derived from different extra-intestinal compartments including a liver (IFN-γ, nitric 
oxide, TNF-α) and b kidney (IFN-γ, nitric oxide, MCP-1). Naive mice served as negative controls (open diamonds). Numbers of mice (in parentheses), 
medians (black bars) and significance levels (p values) determined by Kruskal–Wallis test or ordinary one-way ANOVA are indicated. Data shown 
were pooled from three independent experiments
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comprehensive quantitative survey of the intestinal micro-
biota composition. Cultural and molecular analyses of 
the predominant intestinal bacterial groups revealed that 
differences in the overall microbiota composition of P. aer-
uginosa infected and uninfected hma mice with induced 
ileitis were rather subtle at the first glance. Ileal loads of 
Fig. 8 Systemic cytokine responses in multidrug resistant P. aeruginosa infected human microbiota-associated mice suffering from acute ileitis. 
Human microbiota-associated mice were perorally challenged with T. gondii ME49 to induce acute ileitis and either additionally infected with MDR 
P. aeruginosa 3 days following ileitis induction (PA; filled circles) or not (N; open circles). At day 7 post ileitis induction secretion of distinct pro- and 
anti-inflammatory cytokines were determined in systemic compartments such as a serum (IFN-γ, TNF-α, MCP-1, IL-12p70, IL-6 and IL-10) and b 
spleen (IFN-γ). Naive mice served as negative controls (open diamonds). Numbers of mice (in parentheses), medians (black bars) and significance 
levels (p values) determined by Kruskal–Wallis test or ordinary one-way ANOVA are indicated. Data shown were pooled from three independent 
experiments
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bifidobacteria, however, were more than two orders of 
magnitude lower following P. aeruginosa infection. As 
commensal residents with beneficial effects for intestinal 
homeostasis, bifidobacteria contribute to mucosal barrier 
functions directed against pathogenic colonization of the 
vertebrate host [33, 34]. Two bifidobacterial strains that 
were isolated from resident infant human gastrointesti-
nal microbiota exerted antibacterial activity against sev-
eral pathogens such as S. typhimurium, E. coli, Klebsiella 
pneumoniae, Yersinia pseudotuberculosis, Staphylococcus 
aureus and P. aeruginosa in vitro [34]. In addition, in vitro 
as well as in  vivo studies revealed that Bifidobacterium 
animalis AHC7, for instance, exerts an anti-inflamma-
tory effect through the attenuation of NF-κB activation 
in response to murine S. typhimurium infection and that 
stimulation of dendritic cells with B. animalis AHC7 sig-
nificantly increased CD25+Foxp3+ T cell (Treg) numbers 
[35]. We could further show previously that conventionally 
colonized mice deficient in the innate immune-receptor 
nucleotide-oligomerization-domaine-2 (NOD2) were vir-
tually lacking the bifidobacterial population in their intes-
tines and (at least in part) exhibited compromised host 
resistance, reduced local anti-inflammatory and increased 
systemic pro-inflammatory immune response upon pero-
ral high dose T. gondii infection [29].
Given that acute T. gondii induced ileitis is highly 
dependent on Toll-like Receptor (TLR)-4 mediated sign-
aling of lipopolysaccharide derived from Gram-negative 
intestinal commensals [11, 15], one could speculate 
that additional infection with a Gram-negative bacte-
rium such as P. aeruginosa might further exacerbate the 
induced inflammatory process. Our study, however, 
revealed that clinical and ileal changes, the profound 
influx of innate and adaptive immune cells into the distal 
small intestines and increased secretion of pro-inflam-
matory cytokines in ileum and MLN following T. gondii 
infection were not further aggravated by MDR P. aerugi-
nosa infection. This is surprising considering the pleth-
ora of virulence factors of P. aeruginosa. For instance, 
Pseudomonas lipid A, a core component of bacterial 
lipopeptide, has been shown to activate NFκB signal-
ing through TLR-4 and subsequent pro-inflammatory 
cytokine secretion [36]. In turn, neutrophils are recruited 
to the infection site and contribute to the inflammatory 
host response to P. aeruginosa [1]. One needs to take into 
consideration, however, that peroral high dose T. gondii 
infection (irrespective whether performed with 50 or 100 
cysts) results in a profound Th1-driven hyper-inflamma-
tory scenario (“cytokine tsunami”) [13] that cannot fur-
ther be deteriorated by additional MDR P. aeruginosa 
infection. Strikingly, we were able to observe elevated 
IFN-γ secretion not only in ileal, but also colonic ex vivo 
biopsies 7 days post ileitis induction. To our best knowl-
edge, the terminal ileum has been reported as exclusive 
predilection site following peroral high dose T. gondii 
infection of conventionally colonized mice so far [13].
Fig. 9 Translocating intestinal bacteria in multidrug resistant P. aeruginosa infected human microbiota-associated mice suffering from acute ileitis. 
Human microbiota-associated mice were perorally challenged with T. gondii ME49 to induce acute ileitis and either additionally infected with MDR 
P. aeruginosa 3 days following ileitis induction (PA; filled bars) or not (N; open bars). At day 7 post ileitis induction translocation rates of a intestinal 
bacterial species and of b P. aeruginosa to extra-intestinal and systemic compartments were determined by cultivation of homogenated ex vivo 
biopsies derived from mesenteric lymph nodes (MLN), liver, lung and spleen (direct plating on solid media) and of cardiac blood (in thioglycolate 
enrichment broths) with subsequent subcultivation and species identification. Mean translocation rates (%) ±SD and absolute numbers of positive 
samples out of total number analyzed (in parentheses) are indicated. Data shown were pooled from three independent experiments
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Remarkably, extra-intestinal sequelae of acute ileitis 
induction were further amplified by P. aeruginosa chal-
lenge as indicated by even more pronounced increases 
in hepatic TNF-α concentrations following P. aerugi-
nosa infection of T. gondii pre-infected mice. Potential 
inflammatory effects of MDR P. aeruginosa infection in 
the small intestines (and beyond) should therefore be 
more distinctly deciphered either in a less acute (i.e. less 
severe) or more chronic infection model following pero-
ral low dose infection with less than 10 cysts of T. gon-
dii, for instance. To the best of our knowledge, however, 
a chronic T. gondii ileitis model has not been established 
so far. Alternatively, experimental models of large intesti-
nal inflammation could be applied to investigate host sus-
ceptibility and the pro-inflammatory potential of peroral 
MDR P. aeruginosa infection during intestinal inflamma-
tion in a better discriminatory way than with the model 
used here. To address this, the murine dextran sulfate 
sodium induced colitis model would be a promising can-
didate, for instance.
In the present study we were further able to demon-
strate that anti-inflammatory IL-10 levels were multifold 
increased in the MLN following ileitis induction, but 
even more distinctly upon additional P. aeruginosa infec-
tion, whereas conversely, serum IL-10 concentrations 
were lower in P. aeruginosa infected as compared to non-
infected hma mice suffering from acute ileitis. Hence, the 
more pronounced intestinal anti-inflammatory response 
upon P. aeruginosa application was not sufficient to coun-
teract the pro-inflammatory sequelae caused by T. gon-
dii and P. aeruginosa co-infection. One might have also 
expected comparable increases in systemic IL-10 levels, 
given that translocation of viable bacteria originating 
from the intestinal microbiota to systemic compartments 
such as spleen and blood had occurred more frequently 
in P. aeruginosa co-infected versus non-infected hma 
mice with acute ileitis.
We were finally able to show that viable intestinal bac-
teria were more frequently detected in systemic com-
partments such as spleen and blood of P. aeruginosa 
infected as compared to uninfected hma mice with 
induced ileitis indicating that (even though not other-
wise determined in our study) epithelial barrier leakage 
was supposably even more pronounced by P. aeruginosa 
co-challenge than by acute ileitis induction alone, fur-
ther facilitating bacterial translocation to extra-intes-
tinal including systemic sites. Notably, several studies 
illustrate a link between the etiology of inflammatory 
bowel diseases (IBD) including Crohn’s disease and the 
abundance of Pseudomonas species such as P. fluorescens 
within the intestinal mucosa [37–39]. Solid data regard-
ing the role of P. aeruginosa in IBD pathogenesis, how-
ever, are scarce. One study applying molecular analysis 
of Pseudomonas specific 16S RNA in ileal tissue samples 
derived from children suffering from Crohn’s disease 
revealed a higher prevalence of several Pseudomonas 
species including P. proteolytica and P. brenneri in pedi-
atric Crohn’s disease patients as compared to control 
individuals without IBD, whereas interestingly P. aerug-
inosa could be detected in non-IBD patients only [40]. 
In patients suffering from irritable bowel disease, how-
ever, detection rates of P. aeruginosa specific 16S RNA 
were increased in duodenal mucosa-associated biop-
sies and fecal samples [8]. Furthermore, a case report 
of a child suffering from ulcerative colitis revealed that 
P. aeruginosa 16S rRNA could be identified in colonic 
biopsies [9]. Already an older study from 1966 suggested 
a temporal correlation between identical P. aeruginosa 
strains isolated from patients’ lesions and feces point-
ing towards a spread of viable P. aeruginosa via the blood 
stream [7]. Meanwhile, there is evidence that the risk of 
developing a clinically manifest P. aeruginosa infection is 
significantly higher upon rectal colonization of patients 
in intensive care units [41].
Conclusion
Taken together, acute small intestinal inflammation 
renders hma mice susceptible to infection with MDR P. 
aeruginosa, but P. aeruginosa infection does neither fur-
ther deteriorate ileal, nor extra-intestinal sequelae of ile-
itis induction. We conclude that intestinal inflammation 
might also pose particularly hospitalized patients at risk 
for acquisition of MDR Gram-negative bacteria includ-
ing P. aeruginosa. Given the importance of the interac-
tion between P. aeruginosa, the intestinal microbiota and 
the host immune system as shown here, future studies 
applying less acute and/or more chronic in  vivo infec-
tion models are needed for a better understanding of the 
underlying molecular mechanisms.
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